Treating Graves' orbitopathy: where are we?

Endocrine. 2012 Apr;41(2):167-8. doi: 10.1007/s12020-012-9607-1.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adipocytes, White / drug effects*
  • Adipogenesis / drug effects*
  • Animals
  • Antithyroid Agents / therapeutic use*
  • Down-Regulation / drug effects*
  • Female
  • Graves Ophthalmopathy / drug therapy*
  • Graves Ophthalmopathy / radiotherapy*
  • Graves Ophthalmopathy / surgery*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Radiopharmaceuticals / therapeutic use*
  • Thalidomide / pharmacology*
  • Thyroidectomy*

Substances

  • Antithyroid Agents
  • Immunosuppressive Agents
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Thalidomide